Jakko van Ingen

18.8k citations

247 papers · 8.4k indexed · 3 hit papers · h-index 52

Impact in

Small Animals top 0.02%
- Infectious Diseases and Mycology
Infectious Diseases top 0.1%
- Tuberculosis Research and Epidemiology

Papers in

Small Animals 93
- Infectious Diseases and Mycology 93
Infectious Diseases 177
- Tuberculosis Research and Epidemiology 172

Co-authors: Dick van Soolingen Martin J. Boeree Wouter Hoefsloot P.N.R. Dekhuijzen Johan W. Mouton Charles L. Daley Rob E. Aarnoutse Beatriz E. Ferro
Journals: Antimicrobial Agents and Chemotherapy (18 papers)Journal of Clinical Microbiology (16 papers)Journal of Antimicrobial Chemotherapy (13 papers)The International Journal of Tuberculosis and Lung Disease (11 papers)Clinical Microbiology and Infection (10 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Jakko van Ingen

232 papers receiving 8.2k citations

Hit Papers

align trajectories log scale

Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review 2022 · 145 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 International Journal of Infectious Diseases
2015 Thorax
2015 Thorax

Peers

Countries citing papers authored by Jakko van Ingen

Since Specialization

Citations

This map shows the geographic impact of Jakko van Ingen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakko van Ingen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakko van Ingen more than expected).

Fields of papers citing papers by Jakko van Ingen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakko van Ingen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakko van Ingen. The network helps show where Jakko van Ingen may publish in the future.

Co-authors

The 25 scholars most cited alongside Jakko van Ingen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jakko van Ingen Line = papers co-authored together Jakko van Ingen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A systematic review of tetracyclines for nontuberculous mycobacteria: focus on rapidly growing mycobacteria European Respiratory Review ·Charles L. Daley, Patrick A. Flume, Jakko van Ingen, Reeti Khare, Christina Mingora, Minh-Vu H Nguyen, Kevin Winthrop, Beth Shoshana Zha	2025	0
2	Consensus on the management of refractory nontuberculous mycobacterial pulmonary disease European Respiratory Journal ·Diana Moreira‐Sousa, Bianca C. Martins, Ana Aguiar, Marina Pinheiro, Onno W. Akkerman, Timothy R. Aksamit, Stefano Aliberti, Claire Andréjak, Charles L. Daley, Jakko van Ingen, Christoph Lange, Marc Lipman, Michael R. Loebinger, Mateja Janković Makek, Kozo Morimoto, Rachel Thomson, Dirk Wagner, Kevin Winthrop, Jae‐Joon Yim, Raquel Duarte	2025	0
3	Evaluation of a national multidisciplinary meeting for non-tuberculous mycobacterial disease SHILAP Revista de lepidopterología ·Arthur Lemson, Teaghan Koster, Neeltje Carpaij, Cecile Magis‐Escurra, Martin J. Boeree, Ralf Stemkens, Rob E. Aarnoutse, Arjan van Laarhoven, Reinout van Crevel, Jakko van Ingen, Wouter Hoefsloot	2024	2
4	Real-World Patients’ Diagnosis-to-Treatment Journey with Nontuberculous Mycobacterial Pulmonary Disease: A Cross-Sectional Survey Infectious Diseases and Therapy ·Kozo Morimoto, Jack R. Gallagher, Dirk Wagner, David E. Griffith, Jakko van Ingen	2024	3
5	AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) ADDED TO COMBINATION REGIMEN ON RECURRENCE IN NEWLY DIAGNOSED OR RECURRENT MYCOBACTERIUM AVIUM COMPLEX (MAC): THE ARISE STUDY CHEST Journal ·Jakko van Ingen, Eva Terschlüsen, Dayton W. Yuen, Daniel S. May, M.-L. Nevoret, Monika Ciesielska, Dan J. Stein, Kevin C. Mange	2024	0
6	In vitro activity of omadacycline against geographically diverse rapidly growing nontuberculous mycobacteria (NTM) clinical isolates Diagnostic Microbiology and Infectious Disease ·Eva Terschlüsen, Akio Aono, Diane Anastasiou, Alisa W. Serio, Satoshi Mitarai, Jakko van Ingen	2024	0
7	Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts ERJ Open Research ·Michael R. Loebinger, Stefano Aliberti, Charles Haworth, Mateja Janković Makek, Christoph Lange, Natalie Lorent, Apostolos Papavasileiou, Eva Polverino, Gernot Rohde, Nicolas Véziris, Dirk Wagner, Jakko van Ingen	2024	1
8	A loading dose of clofazimine to rapidly achieve steady-state-like concentrations in patients with nontuberculous mycobacterial disease Journal of Antimicrobial Chemotherapy ·Ralf Stemkens, Arthur Lemson, Simon E. Koele, Elin M. Svensson, Lindsey H. M. te Brake, Reinout van Crevel, Martin J. Boeree, Wouter Hoefsloot, Jakko van Ingen, Rob E. Aarnoutse	2024	5
9	Early bactericidal activity studies for pulmonary tuberculosis: A systematic review of methodological aspects International Journal of Antimicrobial Agents ·Simon E. Koele, Patrick Phillips, Caryn M. Upton, Jakko van Ingen, Ulrika S. H. Simonsson, Andreas H. Diacon, Rob E. Aarnoutse, Elin M. Svensson	2023	8
10	Treatment and Outcome of Culture-Confirmed Mycobacterium marinum Disease Open Forum Infectious Diseases ·L Hendrikx, C.L.M. van Hees, Jurriaan E. M. de Steenwinkel, Hannelore I. Bax, Tom Sprong, Bert Mulder, A Jansz, Arjanne van Griethuysen, Ron Bosboom, Annette M. Stemerding, M.I.A. Koetsier, Marco van Coevorden, Bas C. Mourik, Koen D. Quint, Alewijn Ott, Dick van Soolingen, Saskia Kuipers, Reinout van Crevel, Jakko van Ingen	2022	12
11	Interleukin-1 receptor antagonist anakinra as treatment for paradoxical responses in HIV-negative tuberculosis patients: A case series Med ·Cynthia van Arkel, Martin J. Boeree, Cécile Magis-Escurra, Wouter Hoefsloot, Neeltje Carpaij, Jakko van Ingen, Sjoert Pegge, Pascal Wielders, Frank W.J.M. Smeenk, Rob E. Aarnoutse, Mihai G. Netea, Reinout van Crevel, Arjan van Laarhoven	2022	11
12	Clinical characteristics and an evaluation of predictors for a favourable outcome of Mycobacterium abscessus otomastoiditis: a systematic review and meta-analysis of individual participant data International Journal of Infectious Diseases ·J.M.B. Manders, Theresa Y.S. Leow, Koen van Aerde, Myrthe K. S. Hol, Dirk Kunst, Sjoert Pegge, Thijs Jansen, Jakko van Ingen, Stijn Bekkers	2022	1
13	Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps Journal of Global Antimicrobial Resistance ·Saskia E Mudde, Jodie A. Schildkraut, Nicole C. Ammerman, Corné P. de Vogel, Jurriaan E.M. de Steenwinkel, Jakko van Ingen, Hannelore I. Bax	2022	22
14	Dissemination of Mycobacterium abscessus via global transmission networks Nature Microbiology ·Christopher Ruis, Josephine M. Bryant, Scott C. Bell, Rachel Thomson, Rebecca M. Davidson, Nabeeh A. Hasan, Jakko van Ingen, Michael Strong, R. Andrés Floto, Julian Parkhill	2021	60
15	Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation Respiratory Medicine ·Jodie A. Schildkraut, Jack R. Gallagher, Kozo Morimoto, Christoph Lange, Charles Haworth, R. Andres Floto, Wouter Hoefsloot, David E. Griffith, Dirk Wagner, Jakko van Ingen	2020	28
16	Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial Annals of the American Thoracic Society ·Kevin Winthrop, Patrick A. Flume, Rachel Thomson, Kevin C. Mange, Dayton W. Yuen, Monika Ciesielska, Kozo Morimoto, Stephen J. Ruoss, Luigi Ruffo Codecasa, Jae‐Joon Yim, Theodore K. Marras, Jakko van Ingen, Richard J. Wallace, Barbara A. Brown‐Elliott, Chris Coulter, David E. Griffith	2020	46
17	The tough process of unmasking the slow-growing mycobacterium: case report of Mycobacterium microti infection Access Microbiology ·Cornelia A. M. van de Weg, Jurriaan E.M. de Steenwinkel, Jelle Miedema, Marleen Bakker, Jakko van Ingen, Wouter Hoefsloot	2019	6
18	Lipotoerisme, niet zonder risico's? Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·Hannelore Bax, Jakko van Ingen, Roy S. Dwarkasing, Annelies Verbon	2014	1
19	[Lipotourism, not without risks: a complication of cosmetic surgery abroad]. PubMed ·Bax Hi, Jakko van Ingen, Dwarkasing Rs, Annelies Verbon	2014	5
20	Invasive Disease Caused by Nontuberculous Mycobacteria, Tanzania Emerging infectious diseases ·John A. Crump, Jakko van Ingen, Anne B. Morrissey, Martin J. Boeree, Daudi Mavura, Britta Swai, Nathan M. Thielman, John Bartlett, Henning Grossman, Venance P. Maro, Dick van Soolingen	2008	36

About Jakko van Ingen

Jakko van Ingen is a scholar working on Small Animals, Infectious Diseases, Epidemiology, Microbiology and Molecular Medicine, having authored 247 papers that have together received 8.4k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (215 papers), Tuberculosis Research and Epidemiology (172 papers), Infectious Diseases and Mycology (93 papers), Quinazolinone synthesis and applications (35 papers), Infectious Diseases and Tuberculosis (21 papers), Diagnosis and treatment of tuberculosis (9 papers), Antibiotic Resistance in Bacteria (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). The work is most often cited by research in Small Animals (2.8k citations), Infectious Diseases (5.8k citations), Microbiology (200 citations), Epidemiology (7.0k citations) and Molecular Medicine (416 citations). Jakko van Ingen has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Dick van Soolingen, Martin J. Boeree, Wouter Hoefsloot, P.N.R. Dekhuijzen, Johan W. Mouton, Charles L. Daley, Rob E. Aarnoutse, Beatriz E. Ferro, David E. Griffith and Rina de Zwaan. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, The International Journal of Tuberculosis and Lung Disease and Clinical Microbiology and Infection.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact